NATCO Pharma has launched generic Pomalidomide capsules in the US. This drug treats blood and bone marrow cancer. It is a generic version of Celgene's Pomalyst. The launch is in partnership with Breckenridge Pharmaceutical. This move aims to make specialty medicines accessible. It offers an affordable solution for patients.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/845bQ6z
via IFTTT
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(134)
-
▼
March
(6)
- Ahead of its time, a GLP-1 drug almost made it out...
- Child hears again 18 months after brain stem impla...
- NATCO Pharma launches generic blood cancer treatme...
- Eli Lilly sticks to premium pricing for its innova...
- All our AI models have scientists in loop, says MS...
- Brain can keep producing new neurons in old age, b...
-
▼
March
(6)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment